Evaluation of Micronutrients in Obese Patients

NCT ID: NCT04554082

Last Updated: 2020-09-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

107 participants

Study Classification

OBSERVATIONAL

Study Start Date

2015-01-01

Study Completion Date

2020-04-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of the study primarily was to investigate the value of zinc to copper ratio as possible biomarker of trace elements imbalance in morbidly obese subjects undergoing LSG.

Secondly to correlate zinc to copper ratio with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic biomarkers.

Prospective study will be carried out on 120 morbidly obese adult subjects with a body mass index (BMI) score above 40 along with presence of obesity-related comorbidity. Investigations will be measured preoperative and 9 months postoperative after performing Laparoscopic sleeve gastrectomy; for Body mass index (BMI) and waist circumference. As well as for complete blood count and biochemical biomarkers as fasting blood glucose, lipid profile, serum iron and ferritin. Serum Ceruloplasmin, Zn and Cu levels, followed by calculation of zinc to copper ratio. CRP, serum insulin, serum leptin and lipocalin-2 (Lcn2) will be determined.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

CONSORT 2010 Flow Diagram

Materials and methods:

Recruitment Morbidly obese subjects attending clinic at Surgery department for laparoscopic sleeve gastrectomy Alexandria University Hospitals.

Pre-assignment Details adult morbidly obese subjects were included age above 20 years, BMI above 40 Suffering from comorbidities as hypertension, DM, dyslipidemia. Assigned participants were clinically evaluated for comorbidities as hypertension, DM, dyslipidemia.

As well as signs of nutritional deficiency as anemia, brittle nails.

Group Information one group of participants eligible for laparoscopic sleeve gastrectomy were assigned according to their will to participate in study.

Period of evaluation:

First visit: preoperative for clinical assessment of participants, determine BMI and waist circumference and withdrawal of serum blood sample Second visit: within one month after surgery to make sure that no complication occurred after surgery.

Third visit: nine months postoperative for revaluation of participants, determine BMI and waist circumference, and withdrawal of a serum blood sample

Number of participants at initiating the period of study. They were 120 morbidly obese subjects. Number of participants at the end of the period of study. They were 107 subjects, 13 obese subject withdraw from study as they didn't come during follow up period after 9 months.

Participants according Sex (69 females, and 38 male), with the mean age of 41.6±8.9 years. The mean preoperative BMI was 47.43±5.4 kg/m2. Then, they were evaluated 9 months after LSG.

Preoperative and Postoperative Clinical characteristics and metabolic variables in studied subjects.

Preoperative 9 months postoperative P Body weight (Kg) 129.7 ± 12.1 93.4 ±13.6 0.0013\* BMI (kg/m2) 47.43±5.4 35.7±3.8 0.0052\* Waist circumference (cm) 130.00 ± 4.68 91.82 ± 3.73 0.001\* Systolic BP (mmHg) 146.0±17.0 132.0±11.0 0.001\* Total cholesterol (mmol/L) 5.85 ± 0.41 4.64 ± 0.31 0.035\* Triglycerides (mmol/L) 2.20 ± 0.23 1.92 ± 0.24 0.106 HDL cholesterol (mmol/L) 1.23 ± 0.19 1.39 ± 0.2 0.041\* LDL cholesterol (mmol/L) 3.37 ± 0.23 2.97 ± 0.21 0.022\* HOMA-IR 2.64 ± 1.3 1.44 ± 0.81 0.013\* S. Leptin (ng/ml) 102.87 ± 49.16 33.47 ±12.76 0.0001\* CRP (mg/L) 8.4±5.91 3.2±2.98 0.001\* Lipocalin 2 (µg/L) 107.24±36.8 51.6±12.73 0.001\* Albumin (g/dl) 4.05±0.21 3.91±0.29 0.113

\*Statistically significant at (p≤0.05).

Outcome measures:

primarily was to investigate the value of zinc to copper ratio as possible biomarker of TE imbalance in morbidly obese subjects undergoing LSG.

For detection of presence of micronutrient deficiency in morbid obesity in form of zinc to copper ratio and re-evaluate it after loss of weight

Secondly to correlate it with lipocalin 2 (Lcn2) with respect to Anthropometric measurements and other metabolic markers prospectively.

As zinc to copper ratio is considered as biomarker of micronutrient status; therefore, correlate it with other biomarkers of inflammation (lipocalin 2) and other parameters as BMI, FBG to determine if micronutrient status improve after weight loss or not Time frame: 9 months.

Follow-up and outcome parameters:

All studied subjects will be followed up for early postoperative complications (within the first month) as Bleeding or Leak. Then they will be reviewed after 9 months postoperatively for assessment of anthropometric measurements, control of preoperative comorbidities, and manifestations of TE deficiencies (anemia, hair loss, teeth problems, edema. etc.).

Anthropometric parameters

Body mass index (BMI) and waist circumference will be measured preoperative and 9 months postoperative.

Biochemical parameters

Fasting blood samples will be collected from participants prior to surgery and nine months postoperative, after overnight fast and divided into two tubes; EDTA for complete blood count, the rest into plastic tubes and serum sample.

Serum glucose and Total cholesterol, HDL- cholesterol, LDL- cholesterol, and triglyceride, total protein and Albumin. Serum iron (Fe), and ferritin.

Serum insulin, Ceruloplasmin, Zn and Cu levels, CRP and lipocalin-2 (Lcn2) .

Statistical analysis

All data will be analyzed with Statistical Package for the Social Sciences version 20 software (SPSS, Inc., Chicago, IL). Results will be displayed as mean ± SD. Paired Student's t-test used to compare the data pre-operative and nine months postoperative. The chi-squared test used for category variables. Spearman correlation coefficient used to detect the correlation between different variables. Statistical correlations calculated by Pearson's correlation test. P \< 0.05 is considered significant.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Nutritional Disorder

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Preoperative Clinical characteristics and metabolic biomarkers

BMI and biochemical parameters including trace elements in patients undergoing laparoscopic sleeve gastrectomy before surgery

laparoscopic sleeve gastrectomy

Intervention Type PROCEDURE

bariatric surgery to loss weight

9 months' Postoperative metabolic biomarkers

BMI and biochemical parameters including trace elements in patients 9 months after laparoscopic sleeve gastrectomy

laparoscopic sleeve gastrectomy

Intervention Type PROCEDURE

bariatric surgery to loss weight

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

laparoscopic sleeve gastrectomy

bariatric surgery to loss weight

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* micronutrient deficiency in morbid obese subjects Adults.
* BMI above 40
* presence of comorbidities as hypertenion, DM, dislipidemia

Exclusion Criteria

* all causes which might cause micronutrient deficiency as presence of gastroesophageal reflux
* all causes which may cause increase obesity "BMI" as hormonal disturbance ; hypothyroidism or cushing, females receiving contraceptive pills
Minimum Eligible Age

20 Years

Maximum Eligible Age

55 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Alexandria University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

hala mourad demerdash

Consultant Clinical Pathology

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Hala M Demerdash, MD

Role: PRINCIPAL_INVESTIGATOR

Alexandria University Hospitals

References

Explore related publications, articles, or registry entries linked to this study.

Yerlikaya FH, Toker A, Aribas A. Serum trace elements in obese women with or without diabetes. Indian J Med Res. 2013 Feb;137(2):339-45.

Reference Type BACKGROUND
PMID: 23563378 (View on PubMed)

Provided Documents

Download supplemental materials such as informed consent forms, study protocols, or participant manuals.

Document Type: Study Protocol and Statistical Analysis Plan

View Document

Document Type: Informed Consent Form

View Document

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

00018699

Identifier Type: REGISTRY

Identifier Source: secondary_id

00012098

Identifier Type: REGISTRY

Identifier Source: secondary_id

0304707

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Hepatic Energy Fluxes in NASH and NAS Patients
NCT03997422 ACTIVE_NOT_RECRUITING NA